Key Financial Metrics:
1. Core sales growth of 3.7% for the full year
2. Reported net sales of $4.14 billion, a 165% increase versus the previous year
3. Normalized gross margin of 37.2% compared to 38.5% last year
4. Reported operating margin of 12.4% compared to 6.5% in the prior year
5. Reported EPS of $0.34 compared with $0.05 last year
6. Normalized EPS of $0.80, a 43% increase versus the previous year
7. Operating cash flow of $991.5 million for the quarter, a significant increase from $278 million in the prior year
8. Gross debt balance of $11.89 billion, with over $800 million repaid during the quarter

Investment Stance:
Based on the above financial metrics, it is recommended to adopt an 'overweight' investment stance towards the company. The significant progress in core sales growth, operating margin improvement, and strong cash flow generation are positive indicators of the company's financial health. Additionally, the planned divestiture of the Tools segment and the focus on deleveraging the balance sheet demonstrate a commitment to enhancing shareholder value. The projected tax rate of around 23% and the potential discrete tax benefits further add to the favorable investment outlook. With a solid foundation of financial performance and strategic initiatives in place, the company is well-positioned for future growth and value creation for investors.